Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference14 articles.
1. B. J. Meakin, D. A. Lewis, D. Ganderton, and G. Brambilla. Countering challenges posed by mimicry of CFC performance using HFA systems. In R. N. Dalby, P. R. Byron, S. J. Farr, and J. Peart (eds.), Respiratory Drug Delivery-VII, Serentec, Raleigh, pp. 99–107 (2000).
2. S. W. Stein and P. B. Myrdal. A theoretical and experimental analysis of formulation and device parameters affecting solution MDI size distributions. J. Pharm. Sci. 93:2158–2175 (2004).
3. I. Gonda. Development of a systematic theory of suspension inhalation aerosols-I. A framework to study the effects of aggregation on the aerodynamic behaviour of drug particles. Int. J. Pharm. 27:99–116 (1985).
4. P. H. Howarth. Why particle size should affect clinical response to inhaled therapy. J. Aerosol. Med. 14:S27–S34 (2001).
5. L. Harrison, C. Leach, J. Machacek, J. Vanden Burgt, and J. Vogel. Beneficial effects with reduced particle size and CFC-free extrafine aerosol steroid on lung deposition, absorption, efficacy and safety. Am. J. Respir. Crit. Care. Med. 155:A666 (1997).
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献